Abstract
Children with phenylketonuria (PKU) obtain a great deal of their protein and mineral intakes from synthetic elemental formulae devoid of phenylalanine. To assess the effect of such diets and/or the disease on bone mineralization, children with PKU were compared to normal children for many parameters of mineral homeostasis and bone mineralization. A total of 11 children with PKU of mean age 10.9±4.2 years were compared to a large group of normal control children mean age 11.4±4.2, and an age and sex matched subset (n=11). Children with PKU had lower serum calcium (9.1±0.9 vs 10.4±1.9 mg/dl P<0.01) amd magnesium (1.67±1.4 vs 2.07±0.16 mg/dl, P<0.001) but normal values for phosphorus, zinc, and copper. The percentage tubular reabsorption of phosphorus was increased in PKU (93±3% vs 88±6%, P<0.05) suggesting a lower phosphorus intake and/or absorption. Serum 25-hydroxy-vitamin D, parathyroid hormone and 1,25 dihydroxyvitamin D were similar in PKU and control children. Serum albumin and lean body mass by dual energy X-ray absorption were not different suggesting that protein intake was adequate. In the 11 pairs, a decreased bone mineral density was seen for the lumbar spine (0.61±0.15 vs 0.72±0.24 P<0.05), and lower extremities (1.56±0.30 vs 1.87±0.56 P<0.05) by paired t-test. Compared to the total controls and the paired controls, decreases were seen in markers of bone formation; bone alkaline phosphatase, (72±30 vs 126±43 P<0.001), osteocalcin (10.7±3.4 vs 13.1±2.0 P<0.05) and procollagen type I carboxyterminal propeptide. No differences were seen in the bone resorption markers tartrate resistant acid phosphatase and urine Ca/Cr. The changes noted could not be related after age correction to serum phenylalanine levels, protein intake, or mineral intakes. It is unclear whether deficits in bone mineralization relate to the disease process itself or its treatment.
Similar content being viewed by others
Abbreviations
- l,25(OH) 2D:
-
1,25 dihydroxyvitamin D
- 25-OHD :
-
25-hydroxyvitamin D
- B-ALP :
-
bone alkaline phosphatase
- BMD :
-
bone mineral density (bone mineral content/area)
- DXA :
-
dual energy X-ray absorption
- OC :
-
osteocalcin
- Phe :
-
phenylalanine
- PICP :
-
procollagen type 1 carboxyterminal propeptide
- PKU :
-
phenylketonuria
- PTH :
-
parathyroid hormone
- RDA :
-
recommended daily allowence
- SPA :
-
single photon absorptiometry
- TRAP :
-
tartrate resistant acid phosphatase
- U Ca/Cr :
-
urinary calcium/creatinine ratio
References
Allen J, Humphries I, Waters D, Roberts D, Lipson A, Howman-Giles R, Gaskin K (1994) Decreased bone mineral density in children with phenylketonuria. Am J Clin Nutr 59:419–422
Berry H, Silverman F, Sutherland B (1973) Cortical thickness as an indicator of protein nutrition in treated phenylketonuria patients. Frame B, Parfitt AM, Duncan H (eds) Clinical aspects of metabolic bone disease. Excerpta Medica, Amsterdam, pp 338–343
Carson D, Greeves L, Sweeney L, Crone M (1990) Osteopenia and Phenylketonuria. Pediatr Radiol 20:598–599
Fisch R, Feinberg S, Weisberg S, Day D (1991) Bony Changes of PKU Neonates Unrelated to Phenylalanine levels J Inherited Metab Dis 14:890–895
Hillman L, Cassidy J, Johnson L, Lee D, Allen S (1994) Vitamin D metabolism and bone mineralization in children with juvenile rheumatoid arthritis. J Pediatr 124:910–916
Hillman L, Hillman R, Johnson L, Lee D (1991) Bone Mineralization and Mineral Homeostasis in Children with Phenylketonuria (PKU). Pediatr Res 29 : 193A
McMurry M, Chan G, Leonard C, Ernst S (1992) Bone Mineralization Status in children with phenylketonuria-relationship to nutritional intake and phenylalanine control. Am J Clin Nutr 55:997–1004
Murdoch M, Holman G (1964) Roentgenologic Bone Changes in Phenylketonuria. Am J Dis Child 107:523
Wong R, Acosta P, Jones D, Koch R (1970) Mineral Balance in treated Phenylketonuria children. J Am Dietetic Assoc 57:229
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hillman, L., Schlotzhauer, C., Lee, D. et al. Decreased bone mineralization in children with phenylketonuria under treatment. Eur J Pediatr 155 (Suppl 1), S148–S152 (1996). https://doi.org/10.1007/PL00014234
Issue Date:
DOI: https://doi.org/10.1007/PL00014234